The Performance Characteristics of Composite Measures Used in a Randomized Trial Examining Etanercept and Methotrexate as Monotherapy or in Combination in Patients with Psoriatic Arthritis

Coates, L, Merola, J, Mease, P et al. (10 more authors) (2019) The Performance Characteristics of Composite Measures Used in a Randomized Trial Examining Etanercept and Methotrexate as Monotherapy or in Combination in Patients with Psoriatic Arthritis. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Metadata

Authors/Creators:
  • Coates, L
  • Merola, J
  • Mease, P
  • Ogdie, A
  • Gladman, D
  • Strand, V
  • van Mens, L
  • Liu, L
  • Yen, PK
  • Collier, D
  • Kricorian, G
  • Chung, J
  • Helliwell, P
Keywords: Disease Activity, etanercept and PASDAS, methotrexate (MTX), Psoriatic arthritis
Dates:
  • Published: 29 October 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 09 Nov 2020 14:57
Last Modified: 09 Nov 2020 16:09
Status: Published
Identification Number: https://doi.org/10.1002/art.41108
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics